Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor
Vadim Cherezov,1*
Daniel M. Rosenbaum,2*
Michael A. Hanson,1
Søren G. F. Rasmussen,2
Foon Sun Thian,2
Tong Sun Kobilka,2
Hee-Jung Choi,2,3
Peter Kuhn,4
William I. Weis,2,3
Brian K. Kobilka,2
Raymond C. Stevens1
Abstract:
Heterotrimeric guanine nucleotide–binding protein (G protein)–coupledreceptors constitute the largest family of eukaryotic signaltransduction proteins that communicate across the membrane.We report the crystal structure of a human β2-adrenergicreceptor–T4 lysozyme fusion protein bound to the partialinverse agonist carazolol at 2.4 angstrom resolution. The structureprovides a high-resolution view of a human G protein–coupledreceptor bound to a diffusible ligand. Ligand-binding site accessibilityis enabled by the second extracellular loop, which is held outof the binding cavity by a pair of closely spaced disulfidebridges and a short helical segment within the loop. Cholesterol,a necessary component for crystallization, mediates an intriguingparallel association of receptor molecules in the crystal lattice.Although the location of carazolol in the β2-adrenergicreceptor is very similar to that of retinal in rhodopsin, structuraldifferences in the ligand-binding site and other regions highlightthe challenges in using rhodopsin as a template model for thislarge receptor family.
1 Department of Molecular Biology, Scripps Research Institute, La Jolla, CA 92037, USA. 2 Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA. 3 Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. 4 Department of Cell Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: stevens{at}scripps.edu (R.C.S.); kobilka{at}stanford.edu (B.K.K.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
RESEARCH ARTICLES
Daniel M. Rosenbaum, Vadim Cherezov, Michael A. Hanson, Søren G. F. Rasmussen, Foon Sun Thian, Tong Sun Kobilka, Hee-Jung Choi, Xiao-Jie Yao, William I. Weis, Raymond C. Stevens, and Brian K. Kobilka (23 November 2007) Science318 (5854), 1266.
[DOI: 10.1126/science.1150609] |Abstract »|Full Text »|PDF »|Authors' Summary »|Supporting Online Material »
PERSPECTIVES
Rama Ranganathan (23 November 2007) Science318 (5854), 1253.
[DOI: 10.1126/science.1151656] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
Valda Vinson and Nancy Gough (27 November 2007) Sci. STKE2007 (414), tw434.
[DOI: 10.1126/stke.4142007tw434] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Fifth Transmembrane Domain of Angiotensin II Type 1 Receptor Participates in the Formation of the Ligand-binding Pocket and Undergoes a Counterclockwise Rotation upon Receptor Activation.
I. Domazet, S. S. Martin, B. J. Holleran, M.-E. Morin, P. Lacasse, P. Lavigne, E. Escher, R. Leduc, and G. Guillemette (2009)
J. Biol. Chem.
284, 31953-31961
|Abstract »|Full Text »|PDF »
Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor.
K.-F. Deml, S. Beermann, D. Neumann, A. Strasser, and R. Seifert (2009)
Mol. Pharmacol.
76, 1019-1030
|Abstract »|Full Text »|PDF »
Dual Activities of Odorants on Olfactory and Nuclear Hormone Receptors.
H. Pick, S. Etter, O. Baud, R. Schmauder, L. Bordoli, T. Schwede, and H. Vogel (2009)
J. Biol. Chem.
284, 30547-30555
|Abstract »|Full Text »|PDF »
Lipid Protein Interactions Couple Protonation to Conformation in a Conserved Cytosolic Domain of G Protein-coupled Receptors.
Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 {micro}m size X-ray synchrotron beam.
V. Cherezov, M. A. Hanson, M. T. Griffith, M. C. Hilgart, R. Sanishvili, V. Nagarajan, S. Stepanov, R. F. Fischetti, P. Kuhn, and R. C. Stevens (2009)
J R Soc Interface
6, S587-S597
|Abstract »|Full Text »|PDF »
Close Encounters of the Oily Kind: Regulation of Transporters by Lipids.
Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization.
K. H. Ahn, A. C. Bertalovitz, D. F. Mierke, and D. A. Kendall (2009)
Mol. Pharmacol.
76, 833-842
|Abstract »|Full Text »|PDF »
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
L. Rihakova, C. Quiniou, F. F. Hamdan, R. Kaul, S. Brault, X. Hou, I. Lahaie, P. Sapieha, D. Hamel, Z. Shao, et al. (2009)
Am J Physiol Regulatory Integrative Comp Physiol
297, R1009-R1018
|Abstract »|Full Text »|PDF »
Order of lipid phases in model and plasma membranes.
H.-J. Kaiser, D. Lingwood, I. Levental, J. L. Sampaio, L. Kalvodova, L. Rajendran, and K. Simons (2009)
PNAS
106, 16645-16650
|Abstract »|Full Text »|PDF »
Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor.
M. Clement, J. Cabana, B. J. Holleran, R. Leduc, G. Guillemette, P. Lavigne, and E. Escher (2009)
J. Biol. Chem.
284, 26603-26612
|Abstract »|Full Text »|PDF »
Analysis of Students' Aptitude to Provide Meaning to Images that Represent Cellular Components at the Molecular Level.
H.-R. Dahmani, P. Schneeberger, and I. M. Kramer (2009)
CBE Life Sci Educ
8, 226-238
|Abstract »|Full Text »|PDF »
Coarse-grained modeling of allosteric regulation in protein receptors.
Structural waters define a functional channel mediating activation of the GPCR, rhodopsin.
T. E. Angel, S. Gupta, B. Jastrzebska, K. Palczewski, and M. R. Chance (2009)
PNAS
106, 14367-14372
|Abstract »|Full Text »|PDF »
Differential Effect of Membrane Cholesterol Removal on {micro}- and {delta}-Opioid Receptors: A PARALLEL COMPARISON OF ACUTE AND CHRONIC SIGNALING TO ADENYLYL CYCLASE.
E. S. Levitt, M. J. Clark, P. M. Jenkins, J. R. Martens, and J. R. Traynor (2009)
J. Biol. Chem.
284, 22108-22122
|Abstract »|Full Text »|PDF »
Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor.
F. Gao, K. G. Harikumar, M. Dong, P. C.-H. Lam, P. M. Sexton, A. Christopoulos, A. Bordner, R. Abagyan, and L. J. Miller (2009)
Mol. Pharmacol.
76, 264-274
|Abstract »|Full Text »|PDF »
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.
S. Neumann, W. Huang, S. Titus, G. Krause, G. Kleinau, A. T. Alberobello, W. Zheng, N. T. Southall, J. Inglese, C. P. Austin, et al. (2009)
PNAS
106, 12471-12476
|Abstract »|Full Text »|PDF »
Probing the role of the cation-{pi} interaction in the binding sites of GPCRs using unnatural amino acids.
M. M. Torrice, K. S. Bower, H. A. Lester, and D. A. Dougherty (2009)
PNAS
106, 11919-11924
|Abstract »|Full Text »|PDF »
Pirenzepine Promotes the Dimerization of Muscarinic M1 Receptors through a Three-step Binding Process.
B. Ilien, N. Glasser, J.-P. Clamme, P. Didier, E. Piemont, R. Chinnappan, S. B. Daval, J.-L. Galzi, and Y. Mely (2009)
J. Biol. Chem.
284, 19533-19543
|Abstract »|Full Text »|PDF »
Structural and kinetic modeling of an activating helix switch in the rhodopsin-transducin interface.
P. Scheerer, M. Heck, A. Goede, J. H. Park, H.-W. Choe, O. P. Ernst, K. P. Hofmann, and P. W. Hildebrand (2009)
PNAS
106, 10660-10665
|Abstract »|Full Text »|PDF »
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.
X. J. Yao, G. Velez Ruiz, M. R. Whorton, S. G. F. Rasmussen, B. T. DeVree, X. Deupi, R. K. Sunahara, and B. Kobilka (2009)
PNAS
106, 9501-9506
|Abstract »|Full Text »|PDF »
Selection and characterization of DARPins specific for the neurotensin receptor 1.
P. Milovnik, D. Ferrari, C. A. Sarkar, and A. Pluckthun (2009)
Protein Eng. Des. Sel.
22, 357-366
|Abstract »|Full Text »|PDF »
Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5.
S. E. Hall, A. Mao, V. Nicolaidou, M. Finelli, E. L. Wise, B. Nedjai, J. Kanjanapangka, P. Harirchian, D. Chen, V. Selchau, et al. (2009)
Mol. Pharmacol.
75, 1325-1336
|Abstract »|Full Text »|PDF »
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors.
Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
R Nunez Miguel, J Sanders, D Y Chirgadze, J Furmaniak, and B Rees Smith (2009)
J. Mol. Endocrinol.
42, 381-395
|Abstract »|Full Text »|PDF »
Nonpeptidergic Allosteric Antagonists Differentially Bind to the CXCR2 Chemokine Receptor.
P. de Kruijf, J. van Heteren, H. D. Lim, P. G.M. Conti, M. M. C. van der Lee, L. Bosch, K.-K. Ho, D. Auld, M. Ohlmeyer, M. J. Smit, et al. (2009)
J. Pharmacol. Exp. Ther.
329, 783-790
|Abstract »|Full Text »|PDF »
Multifaceted Approach to Determine the Antagonist Molecular Mechanism and Interaction of Ibodutant ([1-(2-Phenyl-1R-{[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl}-ethylcarbamoyl)-cyclopentyl]-amide) at the Human Tachykinin NK2 Receptor.
S. Meini, F. Bellucci, C. Catalani, P. Cucchi, A. Giolitti, P. Santicioli, and S. Giuliani (2009)
J. Pharmacol. Exp. Ther.
329, 486-495
|Abstract »|Full Text »|PDF »
Helix 8 of leukotriene B4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum.
D. Yasuda, T. Okuno, T. Yokomizo, T. Hori, N. Hirota, T. Hashidate, M. Miyano, T. Shimizu, and M. Nakamura (2009)
FASEB J
23, 1470-1481
|Abstract »|Full Text »|PDF »
Structure-based discovery of {beta}2-adrenergic receptor ligands.
P. Kolb, D. M. Rosenbaum, J. J. Irwin, J. J. Fung, B. K. Kobilka, and B. K. Shoichet (2009)
PNAS
106, 6843-6848
|Abstract »|Full Text »|PDF »
Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog.
J. A. Auchampach, L. M. Kreckler, T. C. Wan, J. E. Maas, D. van der Hoeven, E. Gizewski, J. Narayanan, and G. E. Maas (2009)
J. Pharmacol. Exp. Ther.
329, 2-13
|Abstract »|Full Text »|PDF »
Anterograde Trafficking of G Protein-Coupled Receptors: Function of the C-Terminal F(X)6LL Motif in Export from the Endoplasmic Reticulum.
M. T. Duvernay, C. Dong, X. Zhang, F. Zhou, C. D. Nichols, and G. Wu (2009)
Mol. Pharmacol.
75, 751-761
|Abstract »|Full Text »|PDF »
Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors.
L. P. Pellissier, J. Sallander, M. Campillo, F. Gaven, E. Queffeulou, M. Pillot, A. Dumuis, S. Claeysen, J. Bockaert, and L. Pardo (2009)
Mol. Pharmacol.
75, 982-990
|Abstract »|Full Text »|PDF »
Identification of two distinct inactive conformations of the {beta}2-adrenergic receptor reconciles structural and biochemical observations.
R. O. Dror, D. H. Arlow, D. W. Borhani, M. O. Jensen, S. Piana, and D. E. Shaw (2009)
PNAS
106, 4689-4694
|Abstract »|Full Text »|PDF »
Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor.
A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert (2009)
Mol. Pharmacol.
75, 454-465
|Abstract »|Full Text »|PDF »
Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation.
C. S. Sum, I. G. Tikhonova, S. Costanzi, and M. C. Gershengorn (2009)
J. Biol. Chem.
284, 3529-3536
|Abstract »|Full Text »|PDF »
Comparative analysis of the packing topology of structurally important residues in helical membrane and soluble proteins.
Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine Receptors.
G. Lebon, C. J. Langmead, B. G. Tehan, and E. C. Hulme (2009)
Mol. Pharmacol.
75, 331-341
|Abstract »|Full Text »|PDF »
Engineered Protein Connectivity to Actin Mimics PDZ-dependent Recycling of G Protein-coupled Receptors but Not Its Regulation by Hrs.
B. E. L. Lauffer, S. Chen, C. Melero, T. Kortemme, M. von Zastrow, and G. A. Vargas (2009)
J. Biol. Chem.
284, 2448-2458
|Abstract »|Full Text »|PDF »
The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains G{alpha}i and Downstream Signaling Cascade Activation.
R. Schroder, N. Merten, J. M. Mathiesen, L. Martini, A. Kruljac-Letunic, F. Krop, A. Blaukat, Y. Fang, E. Tran, T. Ulven, et al. (2009)
J. Biol. Chem.
284, 1324-1336
|Abstract »|Full Text »|PDF »
C. Monnier, C. Dode, L. Fabre, L. Teixeira, G. Labesse, J.-P. Pin, J.-P. Hardelin, and P. Rondard (2009)
Hum. Mol. Genet.
18, 75-81
|Abstract »|Full Text »|PDF »
Ligand Selectivity of D2 Dopamine Receptors Is Modulated by Changes in Local Dynamics Produced by Sodium Binding.
S. S. Ericksen, D. F. Cummings, H. Weinstein, and J. A. Schetz (2009)
J. Pharmacol. Exp. Ther.
328, 40-54
|Abstract »|Full Text »|PDF »
Functional Characterization and Structural Modeling of Obesity Associated Mutations in the Melanocortin 4 Receptor.
K. Tan, I. D. Pogozheva, G. S. H. Yeo, D. Hadaschik, J. M. Keogh, C. Haskell-Leuvano, S. O'Rahilly, H. I. Mosberg, and I. S. Farooqi (2009)
Endocrinology
150, 114-125
|Abstract »|Full Text »|PDF »
Topology of Class A G Protein-Coupled Receptors: Insights Gained from Crystal Structures of Rhodopsins, Adrenergic and Adenosine Receptors.
An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors.
H. Lan, M. M. Teeter, V. V. Gurevich, and K. A. Neve (2009)
Mol. Pharmacol.
75, 19-26
|Abstract »|Full Text »|PDF »
Overlapping Binding Site for the Endogenous Agonist, Small-Molecule Agonists, and Ago-allosteric Modulators on the Ghrelin Receptor.
B. Holst, T. M. Frimurer, J. Mokrosinski, T. Halkjaer, K. B. Cullberg, C. R. Underwood, and T. W. Schwartz (2009)
Mol. Pharmacol.
75, 44-59
|Abstract »|Full Text »|PDF »
Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities.
SDR: a database of predicted specificity-determining residues in proteins.
J. E. Donald and E. I. Shakhnovich (2009)
Nucleic Acids Res.
37, D191-D194
|Abstract »|Full Text »|PDF »
SuperScent--a database of flavors and scents.
M. Dunkel, U. Schmidt, S. Struck, L. Berger, B. Gruening, J. Hossbach, I. S. Jaeger, U. Effmert, B. Piechulla, R. Eriksson, et al. (2009)
Nucleic Acids Res.
37, D291-D294
|Abstract »|Full Text »|PDF »
Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor.
M. Foucaud, E. Marco, C. Escrieut, C. Low, B. Kalindjian, and D. Fourmy (2008)
J. Biol. Chem.
283, 35860-35868
|Abstract »|Full Text »|PDF »
Antithyroid Drugs Are 65 Years Old: Time for Retirement?.
P. Beck-Peccoz (2008)
Endocrinology
149, 5943-5944
|Full Text »|PDF »
A Low-Molecular-Weight Antagonist for the Human Thyrotropin Receptor with Therapeutic Potential for Hyperthyroidism.
S. Neumann, G. Kleinau, S. Costanzi, S. Moore, J.-k. Jiang, B. M. Raaka, C. J. Thomas, G. Krause, and M. C. Gershengorn (2008)
Endocrinology
149, 5945-5950
|Abstract »|Full Text »|PDF »
Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2.
T. Lee, R. Schwandner, G. Swaminath, J. Weiszmann, M. Cardozo, J. Greenberg, P. Jaeckel, H. Ge, Y. Wang, X. Jiao, et al. (2008)
Mol. Pharmacol.
74, 1599-1609
|Abstract »|Full Text »|PDF »
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist.
V.-P. Jaakola, M. T. Griffith, M. A. Hanson, V. Cherezov, E. Y. T. Chien, J. R. Lane, A. P. IJzerman, and R. C. Stevens (2008)
Science
322, 1211-1217
|Abstract »|Full Text »|PDF »
Two protonation switches control rhodopsin activation in membranes.
M. Mahalingam, K. Martinez-Mayorga, M. F. Brown, and R. Vogel (2008)
PNAS
105, 17795-17800
|Abstract »|Full Text »|PDF »
Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function.
J. L. Wacker, D. B. Feller, X.-B. Tang, M. C. DeFino, Y. Namkung, J. S. Lyssand, A. J. Mhyre, X. Tan, J. B. Jensen, and C. Hague (2008)
J. Biol. Chem.
283, 31068-31078
|Abstract »|Full Text »|PDF »
Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance.
J. Ling, H. Liao, R. Clark, M. S. M. Wong, and D. D. Lo (2008)
J. Biol. Chem.
283, 30585-30595
|Abstract »|Full Text »|PDF »
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2.
D. J. Nicholls, N. P. Tomkinson, K. E. Wiley, A. Brammall, L. Bowers, C. Grahames, A. Gaw, P. Meghani, P. Shelton, T. J. Wright, et al. (2008)
Mol. Pharmacol.
74, 1193-1202
|Abstract »|Full Text »|PDF »
Role of Key Transmembrane Residues in Agonist and Antagonist Actions at the Two Conformations of the Human {beta}1-Adrenoceptor.
J. G. Baker, R. G. W. Proudman, N. C. Hawley, P. M. Fischer, and S. J. Hill (2008)
Mol. Pharmacol.
74, 1246-1260
|Abstract »|Full Text »|PDF »
Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions.
P. J. Gonzalez-Cabrera, E. Jo, M. G. Sanna, S. Brown, N. Leaf, D. Marsolais, M.-T. Schaeffer, J. Chapman, M. Cameron, M. Guerrero, et al. (2008)
Mol. Pharmacol.
74, 1308-1318
|Abstract »|Full Text »|PDF »
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity: MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND.
C. Valant, K. J. Gregory, N. E. Hall, P. J. Scammells, M. J. Lew, P. M. Sexton, and A. Christopoulos (2008)
J. Biol. Chem.
283, 29312-29321
|Abstract »|Full Text »|PDF »
Efficient cell-free production of olfactory receptors: Detergent optimization, structure, and ligand binding analyses.
L. Kaiser, J. Graveland-Bikker, D. Steuerwald, M. Vanberghem, K. Herlihy, and S. Zhang (2008)
PNAS
105, 15726-15731
|Abstract »|Full Text »|PDF »
Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors.
H. D. Lim, A. Jongejan, R. A. Bakker, E. Haaksma, I. J. P. de Esch, and R. Leurs (2008)
J. Pharmacol. Exp. Ther.
327, 88-96
|Abstract »|Full Text »|PDF »
Structural Motifs of Importance for the Constitutive Activity of the Orphan 7TM Receptor EBI2: Analysis of Receptor Activation in the Absence of an Agonist.
T. Benned-Jensen and M. M. Rosenkilde (2008)
Mol. Pharmacol.
74, 1008-1021
|Abstract »|Full Text »|PDF »
Engineering G protein-coupled receptor expression in bacteria.
G. Skretas and G. Georgiou (2008)
PNAS
105, 14747-14748
|Full Text »|PDF »
From the Cover: Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity.
C. A. Sarkar, I. Dodevski, M. Kenig, S. Dudli, A. Mohr, E. Hermans, and A. Pluckthun (2008)
PNAS
105, 14808-14813
|Abstract »|Full Text »|PDF »
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12.
C. T. Veldkamp, C. Seibert, F. C. Peterson, N. B. De la Cruz, J. C. Haugner III, H. Basnet, T. P. Sakmar, and B. F. Volkman (2008)
Science Signaling
1, ra4
|Abstract »|Full Text »|PDF »
FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
R Nunez Miguel, J Sanders, D Y Chirgadze, T L Blundell, J Furmaniak, and B Rees Smith (2008)
J. Mol. Endocrinol.
41, 145-164
|Abstract »|Full Text »|PDF »
Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor.
A. Strasser, H.-J. Wittmann, and R. Seifert (2008)
J. Pharmacol. Exp. Ther.
326, 783-791
|Abstract »|Full Text »|PDF »
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor.
F. Magnani, Y. Shibata, M. J. Serrano-Vega, and C. G. Tate (2008)
PNAS
105, 10744-10749
|Abstract »|Full Text »|PDF »
A Novel Adrenocorticotropin Receptor Mutation Alters Its Structure and Function, Causing Familial Glucocorticoid Deficiency.
R. A. Artigas, A. Gonzalez, E. Riquelme, C. A. Carvajal, A. Cattani, A. Martinez-Aguayo, A. M. Kalergis, T. Perez-Acle, and C. E. Fardella (2008)
J. Clin. Endocrinol. Metab.
93, 3097-3105
|Abstract »|Full Text »|PDF »
Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.
G. Kleinau, H. Jaeschke, S. Mueller, B. M. Raaka, S. Neumann, R. Paschke, and G. Krause (2008)
FASEB J
22, 2798-2808
|Abstract »|Full Text »|PDF »
Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding.
M. Dong, P. C.-H. Lam, D. I. Pinon, P. M. Sexton, R. Abagyan, and L. J. Miller (2008)
Mol. Pharmacol.
74, 413-422
|Abstract »|Full Text »|PDF »
Extended Hormone Binding Site of the Human Thyroid Stimulating Hormone Receptor: DISTINCTIVE ACIDIC RESIDUES IN THE HINGE REGION ARE INVOLVED IN BOVINE THYROID STIMULATING HORMONE BINDING AND RECEPTOR ACTIVATION.
S. Mueller, G. Kleinau, H. Jaeschke, R. Paschke, and G. Krause (2008)
J. Biol. Chem.
283, 18048-18055
|Abstract »|Full Text »|PDF »
Crystal Structure of Squid Rhodopsin with Intracellularly Extended Cytoplasmic Region.
T. Shimamura, K. Hiraki, N. Takahashi, T. Hori, H. Ago, K. Masuda, K. Takio, M. Ishiguro, and M. Miyano (2008)
J. Biol. Chem.
283, 17753-17756
|Abstract »|Full Text »|PDF »
From the Cover: High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation.
C. Altenbach, A. K. Kusnetzow, O. P. Ernst, K. P. Hofmann, and W. L. Hubbell (2008)
PNAS
105, 7439-7444
|Abstract »|Full Text »|PDF »
Rhodopsin's active state is frozen like a DEER in the headlights.
T. Huber and T. P. Sakmar (2008)
PNAS
105, 7343-7344
|Full Text »|PDF »
Crystallizing Thinking about the {beta}2-Adrenergic Receptor.
A. K. Shukla, J.-P. Sun, and R. J. Lefkowitz (2008)
Mol. Pharmacol.
73, 1333-1338
|Abstract »|Full Text »|PDF »
Two Amino Acid Substitutions within the First External Loop of CCR5 Induce Human Immunodeficiency Virus-Blocking Antibodies in Mice and Chickens.
C. Pastori, A. Clivio, L. Diomede, R. Consonni, G. M. S. De Mori, R. Longhi, G. Colombo, and L. Lopalco (2008)
J. Virol.
82, 4125-4134
|Abstract »|Full Text »|PDF »
Wide Turn Diversity in Protein Transmembrane Helices Implications for G-Protein-Coupled Receptor and Other Polytopic Membrane Protein Structure and Function.
R. P. Riek, A. A. Finch, G. E. Begg, and R. M. Graham (2008)
Mol. Pharmacol.
73, 1092-1104
|Abstract »|Full Text »|PDF »
Structure of the Complement Factor 5a Receptor-Ligand Complex Studied by Disulfide Trapping and Molecular Modeling.
I. S. Hagemann, D. L. Miller, J. M. Klco, G. V. Nikiforovich, and T. J. Baranski (2008)
J. Biol. Chem.
283, 7763-7775
|Abstract »|Full Text »|PDF »
Multiple Roles for the C-terminal Tail of the Chemokine Scavenger D6.
C. V. McCulloch, V. Morrow, S. Milasta, I. Comerford, G. Milligan, G. J. Graham, N. W. Isaacs, and R. J. B. Nibbs (2008)
J. Biol. Chem.
283, 7972-7982
|Abstract »|Full Text »|PDF »
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.
Conformational thermostabilization of the {beta}1-adrenergic receptor in a detergent-resistant form.
M. J. Serrano-Vega, F. Magnani, Y. Shibata, and C. G. Tate (2008)
PNAS
105, 877-882
|Abstract »|Full Text »|PDF »
Site-specific Incorporation of Keto Amino Acids into Functional G Protein-coupled Receptors Using Unnatural Amino Acid Mutagenesis.
S. Ye, C. Kohrer, T. Huber, M. Kazmi, P. Sachdev, E. C.Y. Yan, A. Bhagat, U. L. RajBhandary, and T. P. Sakmar (2008)
J. Biol. Chem.
283, 1525-1533
|Abstract »|Full Text »|PDF »
GPCR Engineering Yields High-Resolution Structural Insights into 2-Adrenergic Receptor Function.
D. M. Rosenbaum, V. Cherezov, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. S. Kobilka, H.-J. Choi, X.-J. Yao, W. I. Weis, R. C. Stevens, et al. (2007)
Science
318, 1266-1273
|Abstract »|Full Text »|PDF »